Their investigation reveals the pronounced augmentation of anti-tumor activity in CAR T cells through the introduction of a T cell neoplasm fusion gene, CARD11-PIK3R3. The gene discussed is PIK3R3; the disease is T-cell and NK-cell neoplasm.